The FDA advisory committee voted unanimously to approve booster shots for Moderna and recommended them for people 65 and older and at risk.
The FDA will take this into consideration when making their decision in a few days.
Following the FDA’s pending approval, the CDC will then meet to decide who can get it and when.
This comes as a surprise to some after data was said to not be incredibly strong for the support of a third shot for Moderna.
Dr. Peter Marks, the FDA’s top vaccine regulator, addressed the committee Thursday before the vote, telling the panel of experts that the agency encourages “all the different viewpoints” regarding the “complex and evolving” data.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to [email protected].